CXCL8 and prostate carcinoma: The PC-3 prostate cancer cell xenograft study utilising Hsp60-knockdown and mock PC-3 cells in SCID mice demonstrated down-regulation of IL-8 in serum in Hsp60 knockdown xenografts.